Harry R. Davis
Corporate Officer/Principal bei Global Genomics Group
Profil
Harry R.
Davis is currently the Chief Drug Development Officer at Global Genomics Group since 2014.
He holds a doctorate degree from The University of Chicago.
Aktive Positionen von Harry R. Davis
| Unternehmen | Position | Beginn |
|---|---|---|
Global Genomics Group
 Global Genomics Group BiotechnologyHealth Technology Global Genomics Group is an American biotechnology company that develops novel therapeutic solutions. The CEO of the private company is Szilard Voros. | Corporate Officer/Principal | 06.05.2014 |
Ausbildung von Harry R. Davis
| The University of Chicago | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 1 |
|---|---|
Global Genomics Group
Global Genomics Group BiotechnologyHealth Technology Global Genomics Group is an American biotechnology company that develops novel therapeutic solutions. The CEO of the private company is Szilard Voros. | Health Technology |
